These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33859800)

  • 21. Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
    Wu J; Quraishi IH; Zhang Y; Bromwich M; Kaczmarek LK
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous expression of a
    Shore AN; Li K; Safari M; Qunies AM; Spitznagel BD; Weaver CD; Emmitte KA; Frankel WN; Weston MC
    bioRxiv; 2024 Aug; ():. PubMed ID: 37873369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
    Milligan CJ; Li M; Gazina EV; Heron SE; Nair U; Trager C; Reid CA; Venkat A; Younkin DP; Dlugos DJ; Petrovski S; Goldstein DB; Dibbens LM; Scheffer IE; Berkovic SF; Petrou S
    Ann Neurol; 2014 Apr; 75(4):581-90. PubMed ID: 24591078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K
    Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK
    J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
    Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
    Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.
    Barcia G; Chemaly N; Kuchenbuch M; Eisermann M; Gobin-Limballe S; Ciorna V; Macaya A; Lambert L; Dubois F; Doummar D; Billette de Villemeur T; Villeneuve N; Barthez MA; Nava C; Boddaert N; Kaminska A; Bahi-Buisson N; Milh M; Auvin S; Bonnefont JP; Nabbout R
    Neurol Genet; 2019 Dec; 5(6):e363. PubMed ID: 31872048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with
    Mosca I; Freri E; Ambrosino P; Belperio G; Granata T; Canafoglia L; Ragona F; Solazzi R; Filareto I; Castellotti B; Messina G; Gellera C; DiFrancesco JC; Soldovieri MV; Taglialatela M
    Front Cell Neurosci; 2024; 18():1367838. PubMed ID: 38644974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional evaluation of epilepsy-associated KCNT1 variants in multiple cellular systems reveals a predominant gain of function impact on channel properties.
    Hinckley CA; Zhu Z; Chu JH; Gubbels C; Danker T; Cherry JJ; Whelan CD; Engle SJ; Nguyen V
    Epilepsia; 2023 Aug; 64(8):2126-2136. PubMed ID: 37177976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.
    Ishii A; Shioda M; Okumura A; Kidokoro H; Sakauchi M; Shimada S; Shimizu T; Osawa M; Hirose S; Yamamoto T
    Gene; 2013 Dec; 531(2):467-71. PubMed ID: 24029078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy.
    Heron SE; Smith KR; Bahlo M; Nobili L; Kahana E; Licchetta L; Oliver KL; Mazarib A; Afawi Z; Korczyn A; Plazzi G; Petrou S; Berkovic SF; Scheffer IE; Dibbens LM
    Nat Genet; 2012 Nov; 44(11):1188-90. PubMed ID: 23086396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel
    Xie N; Qin W; Deng J; Qi J; Niu D; Lu G; Wang Q
    Transl Neurosci; 2021 Jan; 12(1):330-334. PubMed ID: 34567798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Based Identification and Characterization of Inhibitors of the Epilepsy-Associated K
    Cole BA; Johnson RM; Dejakaisaya H; Pilati N; Fishwick CWG; Muench SP; Lippiat JD
    iScience; 2020 May; 23(5):101100. PubMed ID: 32408169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
    Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsy.
    Cherian C; Appendino JP; Ashtiani S; Federico P; Molnar CP; Kerr M; Khan A; Au PYB; Klein KM
    J Neurol; 2022 Apr; 269(4):2162-2171. PubMed ID: 34537872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potassium Channel Subfamily T Member 1(KCNT1) Pathological Variant Causing Epilepsy Of Infancy With Migrating Focal Seizures: A Case Report.
    Chand P; Angez M; Hameed AN; Kirmani S
    J Pak Med Assoc; 2023 Aug; 73(8):1720-1722. PubMed ID: 37697770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.
    Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R
    Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
    Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
    Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced GABAergic Neuron Excitability, Altered Synaptic Connectivity, and Seizures in a KCNT1 Gain-of-Function Mouse Model of Childhood Epilepsy.
    Shore AN; Colombo S; Tobin WF; Petri S; Cullen ER; Dominguez S; Bostick CD; Beaumont MA; Williams D; Khodagholy D; Yang M; Lutz CM; Peng Y; Gelinas JN; Goldstein DB; Boland MJ; Frankel WN; Weston MC
    Cell Rep; 2020 Oct; 33(4):108303. PubMed ID: 33113364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of Aicardi-Goutières syndrome and
    Møller RS; Zhao L; Shoaff JR; Duno M; Andersen BN; Nguyen V; Fang TC; Kupelian V; Thorén R
    Mol Genet Metab Rep; 2022 Dec; 33():100924. PubMed ID: 36262748
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Iraci N; Carotenuto L; Ciaglia T; Belperio G; Di Matteo F; Mosca I; Carleo G; Giovanna Basilicata M; Ambrosino P; Turcio R; Puzo D; Pepe G; Gomez-Monterrey I; Soldovieri MV; Di Sarno V; Campiglia P; Miceli F; Bertamino A; Ostacolo C; Taglialatela M
    J Med Chem; 2024 Jun; 67(11):9124-9149. PubMed ID: 38782404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.